Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-19 4:05 pm Purchase |
2024-01-10 | 13G | Adicet Bio, Inc. ACET |
Commodore Capital LP | 4,250,000 9.800% |
4,250,000 (New Position) |
Filing History |
| 2023-06-29 4:30 pm Purchase |
2023-06-27 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 6,647,598 15.500% |
6,647,598 (New Position) |
Filing History |
| 2023-03-13 4:00 pm Purchase |
2023-03-03 | 13G | Adicet Bio, Inc. ACET |
TANG CAPITAL PARTNERS LP | 2,271,520 5.300% |
2,271,520 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 0 0.000% |
-2,364,351 (Position Closed) |
Filing History |
| 2023-02-14 12:41 pm Sale |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
Avidity Partners Management LP | 0 0.000% |
-3,034,004 (Position Closed) |
Filing History |
| 2023-02-14 10:01 am Purchase |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
RTW Investments, LP | 4,241,472 9.900% |
1,217,728 (+40.27%) |
Filing History |
| 2023-02-13 3:52 pm Purchase |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
BLACKROCK INC BLK |
2,545,618 5.900% |
2,545,618 (New Position) |
Filing History |
| 2023-02-03 2:02 pm Purchase |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
STATE STREET CORP STT |
2,284,586 5.330% |
2,284,586 (New Position) |
Filing History |
| 2023-01-11 10:57 am Purchase |
2022-12-30 | 13G | Adicet Bio, Inc. ACET |
Cowen Financial Products LLC | 3,143,608 7.340% |
1,138,899 (+56.81%) |
Filing History |
| 2022-12-22 6:07 pm Purchase |
2022-12-12 | 13G | Adicet Bio, Inc. ACET |
EcoR1 Capital LLC | 3,560,700 8.300% |
3,560,700 (New Position) |
Filing History |
| 2022-10-17 4:31 pm Purchase |
2022-10-05 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 2,364,351 5.500% |
2,364,351 (New Position) |
Filing History |
| 2022-08-11 5:00 pm Purchase |
2022-08-01 | 13D | Adicet Bio, Inc. ACET |
Carlyle Group Inc. CG |
2,152,959 5.400% |
2,152,959 (New Position) |
Filing History |
| 2022-04-22 3:58 pm Purchase |
2022-04-01 | 13G | Adicet Bio, Inc. ACET |
Cowen Financial Products LLC | 2,004,709 7.460% |
2,004,709 (New Position) |
Filing History |
| 2022-02-11 6:31 pm Purchase |
2021-12-31 | 13G | Adicet Bio, Inc. ACET |
Avidity Partners Management LP | 3,034,004 7.900% |
1,174,004 (+63.12%) |
Filing History |
| 2021-12-15 2:28 pm Purchase |
2021-12-06 | 13G | Adicet Bio, Inc. ACET |
RTW Investments, LP | 3,023,744 7.910% |
3,023,744 (New Position) |
Filing History |
| 2021-12-14 5:29 pm Purchase |
2021-12-10 | 13D | RESTORBIO INC TORC |
ORBIMED ADVISORS LLC | 6,147,599 15.700% |
214,285 (+3.61%) |
Filing History |
| 2021-03-16 4:18 pm Sale |
2021-03-02 | 13D | Adicet Bio, Inc. ACET |
Abingworth LLP | 1,615,385 5.200% |
-25,336 (-1.54%) |
Filing History |
| 2021-03-08 08:30 am Purchase |
2021-03-02 | 13D | NuCana plc NCNA |
Abingworth LLP | 65,629 5.200% |
65,629 (New Position) |
Filing History |
| 2021-03-08 08:15 am Purchase |
2021-02-12 | 13G | Adicet Bio, Inc. ACET |
Abingworth LLP | 1,640,721 5.200% |
1,640,721 (New Position) |
Filing History |
| 2021-02-23 4:05 pm Purchase |
2021-02-16 | 13G | Adicet Bio, Inc. ACET |
Novartis Bioventures Ltd | 1,366,864 4.360% |
98,011 (+7.72%) |
Filing History |